Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy.
Front Pharmacol
; 14: 1295784, 2023.
Article
de En
| MEDLINE
| ID: mdl-37841932
ABSTRACT
[This corrects the article DOI 10.3389/fphar.2023.1189058.].
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Langue:
En
Journal:
Front Pharmacol
Année:
2023
Type de document:
Article
Pays d'affiliation:
Chine